0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HER2 ADC Drugs Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-22R17813
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global HER2 ADC Drugs Market Research Report 2024
BUY CHAPTERS

Global HER2 ADC Drugs Market Research Report 2024

Code: QYRE-Auto-22R17813
Report
August 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HER2 ADC Drugs Market

The HER2-targeted antibody–drug conjugates (ADCs) trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan (T-DXd) represent a novel class of therapeutics in breast cancer. These drugs augment monoclonal antibodies with a cytotoxic payload, which is attached by a linker, forming the basic structure of an ADC.
The global HER2 ADC Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for HER2 ADC Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HER2 ADC Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of HER2 ADC Drugs include Daiichi Sankyo, Genentech, Inc.(Roche), AstraZeneca, RemeGen, MacroGenics, Takeda, Biokin Pharmaceutical, BioNTech(Yingen Biopharmaceutical), CSPC Pharmaceutical Group, Hengrui Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HER2 ADC Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HER2 ADC Drugs.
The HER2 ADC Drugs market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HER2 ADC Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HER2 ADC Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HER2 ADC Drugs Market Report

Report Metric Details
Report Name HER2 ADC Drugs Market
Segment by Type
  • T-DM1(Kadcyla,Trastuzumab emtansine)
  • T-DXd(DS-8201,Enhertu,Trastuzumab deruxtecan)
  • RC48(Disitamab vedotin)
Segment by Application
  • Hospitals
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Daiichi Sankyo, Genentech, Inc.(Roche), AstraZeneca, RemeGen, MacroGenics, Takeda, Biokin Pharmaceutical, BioNTech(Yingen Biopharmaceutical), CSPC Pharmaceutical Group, Hengrui Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of HER2 ADC Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of HER2 ADC Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the HER2 ADC Drugs Market report?

Ans: The main players in the HER2 ADC Drugs Market are Daiichi Sankyo, Genentech, Inc.(Roche), AstraZeneca, RemeGen, MacroGenics, Takeda, Biokin Pharmaceutical, BioNTech(Yingen Biopharmaceutical), CSPC Pharmaceutical Group, Hengrui Pharmaceuticals

What are the Application segmentation covered in the HER2 ADC Drugs Market report?

Ans: The Applications covered in the HER2 ADC Drugs Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the HER2 ADC Drugs Market report?

Ans: The Types covered in the HER2 ADC Drugs Market report are T-DM1(Kadcyla,Trastuzumab emtansine), T-DXd(DS-8201,Enhertu,Trastuzumab deruxtecan), RC48(Disitamab vedotin)

Recommended Reports

HER2 & Breast Cancer

ADC & Antibody Conjugates

Next-gen Cancer Therapeutics

1 HER2 ADC Drugs Market Overview
1.1 Product Definition
1.2 HER2 ADC Drugs by Type
1.2.1 Global HER2 ADC Drugs Market Value Comparison by Type (2024-2030)
1.2.2 T-DM1(Kadcyla,Trastuzumab emtansine)
1.2.3 T-DXd(DS-8201,Enhertu,Trastuzumab deruxtecan)
1.2.4 RC48(Disitamab vedotin)
1.3 HER2 ADC Drugs by Application
1.3.1 Global HER2 ADC Drugs Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global HER2 ADC Drugs Market Size Estimates and Forecasts
1.4.1 Global HER2 ADC Drugs Revenue 2019-2030
1.4.2 Global HER2 ADC Drugs Sales 2019-2030
1.4.3 Global HER2 ADC Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HER2 ADC Drugs Market Competition by Manufacturers
2.1 Global HER2 ADC Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global HER2 ADC Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global HER2 ADC Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of HER2 ADC Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HER2 ADC Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HER2 ADC Drugs, Product Type & Application
2.7 Global Key Manufacturers of HER2 ADC Drugs, Date of Enter into This Industry
2.8 Global HER2 ADC Drugs Market Competitive Situation and Trends
2.8.1 Global HER2 ADC Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HER2 ADC Drugs Players Market Share by Revenue
2.8.3 Global HER2 ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HER2 ADC Drugs Market Scenario by Region
3.1 Global HER2 ADC Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HER2 ADC Drugs Sales by Region: 2019-2030
3.2.1 Global HER2 ADC Drugs Sales by Region: 2019-2024
3.2.2 Global HER2 ADC Drugs Sales by Region: 2025-2030
3.3 Global HER2 ADC Drugs Revenue by Region: 2019-2030
3.3.1 Global HER2 ADC Drugs Revenue by Region: 2019-2024
3.3.2 Global HER2 ADC Drugs Revenue by Region: 2025-2030
3.4 North America HER2 ADC Drugs Market Facts & Figures by Country
3.4.1 North America HER2 ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HER2 ADC Drugs Sales by Country (2019-2030)
3.4.3 North America HER2 ADC Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe HER2 ADC Drugs Market Facts & Figures by Country
3.5.1 Europe HER2 ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HER2 ADC Drugs Sales by Country (2019-2030)
3.5.3 Europe HER2 ADC Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HER2 ADC Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific HER2 ADC Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HER2 ADC Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific HER2 ADC Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HER2 ADC Drugs Market Facts & Figures by Country
3.7.1 Latin America HER2 ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HER2 ADC Drugs Sales by Country (2019-2030)
3.7.3 Latin America HER2 ADC Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HER2 ADC Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa HER2 ADC Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HER2 ADC Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa HER2 ADC Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HER2 ADC Drugs Sales by Type (2019-2030)
4.1.1 Global HER2 ADC Drugs Sales by Type (2019-2024)
4.1.2 Global HER2 ADC Drugs Sales by Type (2025-2030)
4.1.3 Global HER2 ADC Drugs Sales Market Share by Type (2019-2030)
4.2 Global HER2 ADC Drugs Revenue by Type (2019-2030)
4.2.1 Global HER2 ADC Drugs Revenue by Type (2019-2024)
4.2.2 Global HER2 ADC Drugs Revenue by Type (2025-2030)
4.2.3 Global HER2 ADC Drugs Revenue Market Share by Type (2019-2030)
4.3 Global HER2 ADC Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global HER2 ADC Drugs Sales by Application (2019-2030)
5.1.1 Global HER2 ADC Drugs Sales by Application (2019-2024)
5.1.2 Global HER2 ADC Drugs Sales by Application (2025-2030)
5.1.3 Global HER2 ADC Drugs Sales Market Share by Application (2019-2030)
5.2 Global HER2 ADC Drugs Revenue by Application (2019-2030)
5.2.1 Global HER2 ADC Drugs Revenue by Application (2019-2024)
5.2.2 Global HER2 ADC Drugs Revenue by Application (2025-2030)
5.2.3 Global HER2 ADC Drugs Revenue Market Share by Application (2019-2030)
5.3 Global HER2 ADC Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Daiichi Sankyo HER2 ADC Drugs Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Genentech, Inc.(Roche)
6.2.1 Genentech, Inc.(Roche) Company Information
6.2.2 Genentech, Inc.(Roche) Description and Business Overview
6.2.3 Genentech, Inc.(Roche) HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Genentech, Inc.(Roche) HER2 ADC Drugs Product Portfolio
6.2.5 Genentech, Inc.(Roche) Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca HER2 ADC Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 RemeGen
6.4.1 RemeGen Company Information
6.4.2 RemeGen Description and Business Overview
6.4.3 RemeGen HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 RemeGen HER2 ADC Drugs Product Portfolio
6.4.5 RemeGen Recent Developments/Updates
6.5 MacroGenics
6.5.1 MacroGenics Company Information
6.5.2 MacroGenics Description and Business Overview
6.5.3 MacroGenics HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MacroGenics HER2 ADC Drugs Product Portfolio
6.5.5 MacroGenics Recent Developments/Updates
6.6 Takeda
6.6.1 Takeda Company Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Takeda HER2 ADC Drugs Product Portfolio
6.6.5 Takeda Recent Developments/Updates
6.7 Biokin Pharmaceutical
6.7.1 Biokin Pharmaceutical Company Information
6.7.2 Biokin Pharmaceutical Description and Business Overview
6.7.3 Biokin Pharmaceutical HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Biokin Pharmaceutical HER2 ADC Drugs Product Portfolio
6.7.5 Biokin Pharmaceutical Recent Developments/Updates
6.8 BioNTech(Yingen Biopharmaceutical)
6.8.1 BioNTech(Yingen Biopharmaceutical) Company Information
6.8.2 BioNTech(Yingen Biopharmaceutical) Description and Business Overview
6.8.3 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product Portfolio
6.8.5 BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
6.9 CSPC Pharmaceutical Group
6.9.1 CSPC Pharmaceutical Group Company Information
6.9.2 CSPC Pharmaceutical Group Description and Business Overview
6.9.3 CSPC Pharmaceutical Group HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSPC Pharmaceutical Group HER2 ADC Drugs Product Portfolio
6.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.10 Hengrui Pharmaceuticals
6.10.1 Hengrui Pharmaceuticals Company Information
6.10.2 Hengrui Pharmaceuticals Description and Business Overview
6.10.3 Hengrui Pharmaceuticals HER2 ADC Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hengrui Pharmaceuticals HER2 ADC Drugs Product Portfolio
6.10.5 Hengrui Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HER2 ADC Drugs Industry Chain Analysis
7.2 HER2 ADC Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HER2 ADC Drugs Production Mode & Process
7.4 HER2 ADC Drugs Sales and Marketing
7.4.1 HER2 ADC Drugs Sales Channels
7.4.2 HER2 ADC Drugs Distributors
7.5 HER2 ADC Drugs Customers
8 HER2 ADC Drugs Market Dynamics
8.1 HER2 ADC Drugs Industry Trends
8.2 HER2 ADC Drugs Market Drivers
8.3 HER2 ADC Drugs Market Challenges
8.4 HER2 ADC Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global HER2 ADC Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global HER2 ADC Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global HER2 ADC Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global HER2 ADC Drugs Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global HER2 ADC Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global HER2 ADC Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global HER2 ADC Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market HER2 ADC Drugs Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of HER2 ADC Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of HER2 ADC Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of HER2 ADC Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of HER2 ADC Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global HER2 ADC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER2 ADC Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global HER2 ADC Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global HER2 ADC Drugs Sales by Region (2019-2024) & (kg)
 Table 18. Global HER2 ADC Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global HER2 ADC Drugs Sales by Region (2025-2030) & (kg)
 Table 20. Global HER2 ADC Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global HER2 ADC Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global HER2 ADC Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global HER2 ADC Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global HER2 ADC Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America HER2 ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America HER2 ADC Drugs Sales by Country (2019-2024) & (kg)
 Table 27. North America HER2 ADC Drugs Sales by Country (2025-2030) & (kg)
 Table 28. North America HER2 ADC Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America HER2 ADC Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe HER2 ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe HER2 ADC Drugs Sales by Country (2019-2024) & (kg)
 Table 32. Europe HER2 ADC Drugs Sales by Country (2025-2030) & (kg)
 Table 33. Europe HER2 ADC Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe HER2 ADC Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific HER2 ADC Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific HER2 ADC Drugs Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific HER2 ADC Drugs Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific HER2 ADC Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific HER2 ADC Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America HER2 ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America HER2 ADC Drugs Sales by Country (2019-2024) & (kg)
 Table 42. Latin America HER2 ADC Drugs Sales by Country (2025-2030) & (kg)
 Table 43. Latin America HER2 ADC Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America HER2 ADC Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa HER2 ADC Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa HER2 ADC Drugs Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa HER2 ADC Drugs Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa HER2 ADC Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa HER2 ADC Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global HER2 ADC Drugs Sales (kg) by Type (2019-2024)
 Table 51. Global HER2 ADC Drugs Sales (kg) by Type (2025-2030)
 Table 52. Global HER2 ADC Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global HER2 ADC Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global HER2 ADC Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global HER2 ADC Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global HER2 ADC Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global HER2 ADC Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global HER2 ADC Drugs Price (US$/kg) by Type (2019-2024)
 Table 59. Global HER2 ADC Drugs Price (US$/kg) by Type (2025-2030)
 Table 60. Global HER2 ADC Drugs Sales (kg) by Application (2019-2024)
 Table 61. Global HER2 ADC Drugs Sales (kg) by Application (2025-2030)
 Table 62. Global HER2 ADC Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global HER2 ADC Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global HER2 ADC Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global HER2 ADC Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global HER2 ADC Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global HER2 ADC Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global HER2 ADC Drugs Price (US$/kg) by Application (2019-2024)
 Table 69. Global HER2 ADC Drugs Price (US$/kg) by Application (2025-2030)
 Table 70. Daiichi Sankyo Company Information
 Table 71. Daiichi Sankyo Description and Business Overview
 Table 72. Daiichi Sankyo HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. Daiichi Sankyo HER2 ADC Drugs Product
 Table 74. Daiichi Sankyo Recent Developments/Updates
 Table 75. Genentech, Inc.(Roche) Company Information
 Table 76. Genentech, Inc.(Roche) Description and Business Overview
 Table 77. Genentech, Inc.(Roche) HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. Genentech, Inc.(Roche) HER2 ADC Drugs Product
 Table 79. Genentech, Inc.(Roche) Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. AstraZeneca HER2 ADC Drugs Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. RemeGen Company Information
 Table 86. RemeGen Description and Business Overview
 Table 87. RemeGen HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. RemeGen HER2 ADC Drugs Product
 Table 89. RemeGen Recent Developments/Updates
 Table 90. MacroGenics Company Information
 Table 91. MacroGenics Description and Business Overview
 Table 92. MacroGenics HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. MacroGenics HER2 ADC Drugs Product
 Table 94. MacroGenics Recent Developments/Updates
 Table 95. Takeda Company Information
 Table 96. Takeda Description and Business Overview
 Table 97. Takeda HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. Takeda HER2 ADC Drugs Product
 Table 99. Takeda Recent Developments/Updates
 Table 100. Biokin Pharmaceutical Company Information
 Table 101. Biokin Pharmaceutical Description and Business Overview
 Table 102. Biokin Pharmaceutical HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. Biokin Pharmaceutical HER2 ADC Drugs Product
 Table 104. Biokin Pharmaceutical Recent Developments/Updates
 Table 105. BioNTech(Yingen Biopharmaceutical) Company Information
 Table 106. BioNTech(Yingen Biopharmaceutical) Description and Business Overview
 Table 107. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. BioNTech(Yingen Biopharmaceutical) HER2 ADC Drugs Product
 Table 109. BioNTech(Yingen Biopharmaceutical) Recent Developments/Updates
 Table 110. CSPC Pharmaceutical Group Company Information
 Table 111. CSPC Pharmaceutical Group Description and Business Overview
 Table 112. CSPC Pharmaceutical Group HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. CSPC Pharmaceutical Group HER2 ADC Drugs Product
 Table 114. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 115. Hengrui Pharmaceuticals Company Information
 Table 116. Hengrui Pharmaceuticals Description and Business Overview
 Table 117. Hengrui Pharmaceuticals HER2 ADC Drugs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. Hengrui Pharmaceuticals HER2 ADC Drugs Product
 Table 119. Hengrui Pharmaceuticals Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. HER2 ADC Drugs Distributors List
 Table 123. HER2 ADC Drugs Customers List
 Table 124. HER2 ADC Drugs Market Trends
 Table 125. HER2 ADC Drugs Market Drivers
 Table 126. HER2 ADC Drugs Market Challenges
 Table 127. HER2 ADC Drugs Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of HER2 ADC Drugs
 Figure 2. Global HER2 ADC Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global HER2 ADC Drugs Market Share by Type: 2023 & 2030
 Figure 4. T-DM1(Kadcyla,Trastuzumab emtansine) Product Picture
 Figure 5. T-DXd(DS-8201,Enhertu,Trastuzumab deruxtecan) Product Picture
 Figure 6. RC48(Disitamab vedotin) Product Picture
 Figure 7. Global HER2 ADC Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global HER2 ADC Drugs Market Share by Application: 2023 & 2030
 Figure 9. Hospitals
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global HER2 ADC Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global HER2 ADC Drugs Market Size (2019-2030) & (US$ Million)
 Figure 14. Global HER2 ADC Drugs Sales (2019-2030) & (kg)
 Figure 15. Global HER2 ADC Drugs Average Price (US$/kg) & (2019-2030)
 Figure 16. HER2 ADC Drugs Report Years Considered
 Figure 17. HER2 ADC Drugs Sales Share by Manufacturers in 2023
 Figure 18. Global HER2 ADC Drugs Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest HER2 ADC Drugs Players: Market Share by Revenue in HER2 ADC Drugs in 2023
 Figure 20. HER2 ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global HER2 ADC Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America HER2 ADC Drugs Sales Market Share by Country (2019-2030)
 Figure 23. North America HER2 ADC Drugs Revenue Market Share by Country (2019-2030)
 Figure 24. United States HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe HER2 ADC Drugs Sales Market Share by Country (2019-2030)
 Figure 27. Europe HER2 ADC Drugs Revenue Market Share by Country (2019-2030)
 Figure 28. Germany HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific HER2 ADC Drugs Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific HER2 ADC Drugs Revenue Market Share by Region (2019-2030)
 Figure 35. China HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America HER2 ADC Drugs Sales Market Share by Country (2019-2030)
 Figure 43. Mexico HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa HER2 ADC Drugs Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa HER2 ADC Drugs Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE HER2 ADC Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of HER2 ADC Drugs by Type (2019-2030)
 Figure 53. Global Revenue Market Share of HER2 ADC Drugs by Type (2019-2030)
 Figure 54. Global HER2 ADC Drugs Price (US$/kg) by Type (2019-2030)
 Figure 55. Global Sales Market Share of HER2 ADC Drugs by Application (2019-2030)
 Figure 56. Global Revenue Market Share of HER2 ADC Drugs by Application (2019-2030)
 Figure 57. Global HER2 ADC Drugs Price (US$/kg) by Application (2019-2030)
 Figure 58. HER2 ADC Drugs Value Chain
 Figure 59. HER2 ADC Drugs Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart